SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- Smartee Denti-Technology today released its 2025 annual review, detailing a pivotal year characterized by the worldwide clinical application of...
LONDON, Jan. 19, 2026 /PRNewswire/ -- SUNRATE, the global payment and treasury management platform, today announced a new alliance with international travel-technology provider Juniper...
LAS VEGAS, Jan. 19, 2026 /PRNewswire/ -- Looking for a smart life solution, with just verbal communication via a 24/7 personal assistant that actually...
Planned Succession Positions Diversified Conglomerate for Continued Growth Dr. Harry S. Banga to continue leading the Group as Founder and Executive Chairman HONG...